Tag: FDA

FDA Approves New Weight-Loss Pill That Can Be Taken Any Time of Day : ScienceAlert

AP – On Wednesday, federal regulators approved a new weight-loss pill from Eli Lilly, marking the second daily

Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is making waves in the biotechnology industry as one of the penny stocks with

FDA briefs lawmakers on food safety priorities

WASHINGTON — Senators were briefed by Food and Drug Administration officials on the agency's 2026 food policy plans,

FDA approved C. diff drugs. Access to treatment got harder

Blanca Morales began inquiring about a transplant after her son Mundo had been ill for four months. His

Becton, Dickinson Recieves FDA Clearance for Surgiphor 1000 ml Irrigation System

Becton, Dickinson and Company (NYSE:BDX) has recently been recognized as one of the 13 Undervalued Dividend Aristocrats to

FDA move on flavored vapes sparks concern on toxicity, teen vaping

“We’ve been talking about gummy bear and bubble gum flavors being the most attractive,” said Chaffee. “I don’t

FDA approves leucovorin for rare disorder, not for autism

The Food and Drug Administration recently approved a drug to treat a rare brain disorder that resembles autism.

FDA Vinay Prasad, Ozempic, autism diagnosis: Morning Rounds

Fresh turmoil at the FDA with Prasad’s exit Vinay Prasad, who served as the head of the Center

FDA advisory committee meetings fade as controversial decisions grow

The Trump administration recently organized a private press conference to address concerns about an experimental treatment for Huntington's

Trump administration’s FDA vaccine chief Vinay Prasad is leaving for the second time : NPR

Embattled FDA Vaccine Chief Dr. Vinay Prasad Leaving Agency for Second Time in a Year In this undated

Arcutis Biotherapeutics Spotlights ZORYVE Surge, 2025 Revenue Beat and Key FDA Milestones at TD Cowen

Arcutis Biotherapeutics, a leading clinical-stage biopharmaceutical company, recently showcased its impressive performance and outlined upcoming regulatory and pipeline

Rare disease advocates perplexed by mixed messages at the FDA

Two years ago, Megan Selser was in the midst of folding her 7-week-old infant’s clothes, holding him close